| Year |
Citation |
Score |
| 2024 |
Luo M, Bao L, Xue Y, Zhu M, Kumar A, Xing C, Wang JE, Wang Y, Luo W. ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2. The Journal of Clinical Investigation. 134. PMID 38488001 DOI: 10.1172/JCI171166 |
0.361 |
|
| 2023 |
Bao L, Kumar A, Zhu M, Peng Y, Xing C, Wang JE, Wang Y, Luo W. SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1. The Journal of Clinical Investigation. 133. PMID 37655663 DOI: 10.1172/JCI168362 |
0.395 |
|
| 2022 |
Zhang B, Chen Y, Bao L, Luo W. GPT2 Is Induced by Hypoxia-Inducible Factor (HIF)-2 and Promotes Glioblastoma Growth. Cells. 11. PMID 36010673 DOI: 10.3390/cells11162597 |
0.435 |
|
| 2022 |
Luo M, Bao L, Chen Y, Xue Y, Wang Y, Zhang B, Wang C, Corley CD, McDonald JG, Kumar A, Xing C, Fang Y, Nelson ER, Wang JE, Wang Y, ... Luo W, et al. ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells. Science Advances. 8: eabn5295. PMID 35857506 DOI: 10.1126/sciadv.abn5295 |
0.374 |
|
| 2021 |
Fang W, Liao C, Shi R, Simon JM, Ptacek TS, Zurlo G, Ye Y, Han L, Fan C, Bao L, Ortiz CL, Lin HR, Manocha U, Luo W, Kim WY, et al. ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer. Elife. 10. PMID 34779768 DOI: 10.7554/eLife.70412 |
0.432 |
|
| 2021 |
Wang Y, Chen Y, Wang C, Yang M, Wang Y, Bao L, Wang JE, Kim B, Chan KY, Xu W, Capota E, Ortega J, Nijhawan D, Li GM, Luo W, et al. MIF is a 3' flap nuclease that facilitates DNA replication and promotes tumor growth. Nature Communications. 12: 2954. PMID 34012010 DOI: 10.1038/s41467-021-23264-z |
0.326 |
|
| 2020 |
Chen L, Bao L, Niu Y, Wang JE, Kumar A, Xing C, Wang Y, Luo W. LncIHAT is induced by hypoxia-inducible factor 1 and promotes breast cancer progression. Molecular Cancer Research : McR. PMID 33380467 DOI: 10.1158/1541-7786.MCR-20-0383 |
0.473 |
|
| 2020 |
Wang Y, Luo M, Chen Y, Wang Y, Zhang B, Ren Z, Bao L, Wang Y, Wang JE, Fu YX, Luo W, Wang Y. ZMYND8 expression in breast cancer cells blocks T-lymphocyte surveillance to promote tumor growth. Cancer Research. PMID 33148660 DOI: 10.1158/0008-5472.CAN-20-1710 |
0.387 |
|
| 2020 |
Moore JA, Hubbi ME, Wang C, Wang Y, Luo W, Hofmann S, Rambally S. Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the Gene. Journal of Investigative Medicine High Impact Case Reports. 8: 2324709620947256. PMID 32755251 DOI: 10.1177/2324709620947256 |
0.731 |
|
| 2020 |
Wang Y, Chen Y, Bao L, Zhang B, Wang JE, Kumar A, Xing C, Wang Y, Luo W. CHD4 promotes breast cancer progression as a coactivator of hypoxia-inducible factors. Cancer Research. PMID 32699137 DOI: 10.1158/0008-5472.Can-20-1049 |
0.543 |
|
| 2020 |
Zhang B, Chen Y, Shi X, Zhou M, Bao L, Hatanpaa KJ, Patel T, DeBerardinis RJ, Wang Y, Luo W. Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma. Cellular and Molecular Life Sciences : Cmls. PMID 32088728 DOI: 10.1007/S00018-020-03483-1 |
0.499 |
|
| 2020 |
Niu Y, Bao L, Chen Y, Wang C, Luo M, Zhang B, Zhou M, Wang JE, Fang YV, Kumar A, Xing C, Wang Y, Luo W. HIF-2-induced long non-coding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and breast cancer metastasis. Cancer Research. PMID 31900259 DOI: 10.1158/0008-5472.Can-19-1532 |
0.545 |
|
| 2019 |
Luo W, Wang Y. Hypoxia Mediates Tumor Malignancy and Therapy Resistance. Advances in Experimental Medicine and Biology. 1136: 1-18. PMID 31201713 DOI: 10.1007/978-3-030-12734-3_1 |
0.396 |
|
| 2019 |
Suh EH, Hackett EP, Wynn RM, Chuang DT, Zhang B, Luo W, Sherry AD, Park JM. In vivo assessment of increased oxidation of branched-chain amino acids in glioblastoma. Scientific Reports. 9: 340. PMID 30674979 DOI: 10.1038/S41598-018-37390-0 |
0.303 |
|
| 2018 |
Chen Y, Wang Y, Luo W. ZMYND8 is a primary HIF coactivator that mediates breast cancer progression. Molecular & Cellular Oncology. 5: e1479619. PMID 30250924 DOI: 10.1080/23723556.2018.1479619 |
0.513 |
|
| 2018 |
Bao L, Chen Y, Lai HT, Wu SY, Wang JE, Hatanpaa KJ, Raisanen JM, Fontenot M, Lega B, Chiang CM, Semenza GL, Wang Y, Luo W. Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration. Nucleic Acids Research. PMID 29860315 DOI: 10.1093/Nar/Gky449 |
0.649 |
|
| 2018 |
Chen Y, Zhang B, Bao L, Jin L, Yang M, Peng Y, Kumar A, Wang JE, Wang C, Zou X, Xing C, Wang Y, Luo W. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. The Journal of Clinical Investigation. PMID 29629903 DOI: 10.1172/Jci95089 |
0.518 |
|
| 2018 |
Chen Y, Zhang B, Bao L, Jin L, Yang M, Peng Y, Wang J, Wang C, Zou X, Wang Y, Luo W. Abstract B52: HIF-ZMYND8-BRD4 axis mediates breast cancer progression and metastasis Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-B52 |
0.512 |
|
| 2018 |
Chen Y, Zhang B, Bao L, Jin L, Yang M, Peng Y, Wang J, Wang C, Zou X, Wang Y, Luo W. Abstract 82: Epigenetic reader ZMYND8 bridges BRD4 and hypoxia-inducible factors to mediate breast cancer progression and metastasis Cancer Research. 78: 82-82. DOI: 10.1158/1538-7445.Am2018-82 |
0.527 |
|
| 2018 |
Bao L, Chen Y, Lai H, Chiang C, Semenza GL, Wang Y, Luo W. Abstract 5427: Inhibition of hypoxia-inducible factor 1 (HIF-1) transcriptional activity and cell mobility via G9a/GLP-mediated methylation of HIF-1α Cancer Research. 78: 5427-5427. DOI: 10.1158/1538-7445.Am2018-5427 |
0.661 |
|
| 2017 |
Luo W, Wang Y. Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity. Cellular and Molecular Life Sciences : Cmls. PMID 29032501 DOI: 10.1007/S00018-017-2684-9 |
0.478 |
|
| 2016 |
Luo W, Chen I, Chen Y, Alkam D, Wang Y, Semenza GL. PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia. Oncotarget. PMID 26837221 DOI: 10.18632/Oncotarget.7142 |
0.649 |
|
| 2015 |
Xiang L, Gilkes DM, Hu H, Luo W, Bullen JW, Liang H, Semenza GL. HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells. Oncotarget. 6: 11768-78. PMID 26059435 DOI: 10.18632/Oncotarget.4190 |
0.811 |
|
| 2015 |
Sur S, Chapiro J, Savic LJ, Kaniappan GS, Reyes J, Duran R, Thiruganasambandam SC, Moats CR, Luo W, Ewald AJ, Zhou S, Kinzler KW, Geschwind J, Vogelstein B. Abstract NG06: The Trojan Horse Strategy: Packaging chemotherapeutics can help alleviate toxicity Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ng06 |
0.328 |
|
| 2015 |
Luo W, Semenza GL. Abstract 525: PHD3-mediated prolyl hydroxylation of non-muscle actin impairs polymerization and cell motility Cancer Research. 75: 525-525. DOI: 10.1158/1538-7445.Am2015-525 |
0.53 |
|
| 2014 |
Xiang L, Gilkes DM, Hu H, Takano N, Luo W, Lu H, Bullen JW, Samanta D, Liang H, Semenza GL. Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype. Oncotarget. 5: 12509-27. PMID 25587023 DOI: 10.18632/Oncotarget.2997 |
0.827 |
|
| 2014 |
Hu H, Takano N, Xiang L, Gilkes DM, Luo W, Semenza GL. Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget. 5: 8853-68. PMID 25326682 DOI: 10.18632/Oncotarget.2593 |
0.79 |
|
| 2014 |
Chapiro J, Sur S, Savic LJ, Ganapathy-Kanniappan S, Reyes J, Duran R, Thiruganasambandam SC, Moats CR, Lin M, Luo W, Tran PT, Herman JM, Semenza GL, Ewald AJ, Vogelstein B, et al. Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6406-17. PMID 25326230 DOI: 10.1158/1078-0432.Ccr-14-1271 |
0.465 |
|
| 2014 |
Luo W, Lin B, Wang Y, Zhong J, O'Meally R, Cole RN, Pandey A, Levchenko A, Semenza GL. PHD3-mediated prolyl hydroxylation of nonmuscle actin impairs polymerization and cell motility. Molecular Biology of the Cell. 25: 2788-96. PMID 25079693 DOI: 10.1091/Mbc.E14-02-0775 |
0.52 |
|
| 2014 |
Wang T, Gilkes DM, Takano N, Xiang L, Luo W, Bishop CJ, Chaturvedi P, Green JJ, Semenza GL. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proceedings of the National Academy of Sciences of the United States of America. 111: E3234-42. PMID 24938788 DOI: 10.1073/Pnas.1410041111 |
0.803 |
|
| 2014 |
Takano N, Peng YJ, Kumar GK, Luo W, Hu H, Shimoda LA, Suematsu M, Prabhakar NR, Semenza GL. Hypoxia-inducible factors regulate human and rat cystathionine β-synthase gene expression. The Biochemical Journal. 458: 203-11. PMID 24328859 DOI: 10.1042/Bj20131350 |
0.613 |
|
| 2014 |
Xiang L, Gilkes DM, Chaturvedi P, Luo W, Hu H, Takano N, Liang H, Semenza GL. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer. Journal of Molecular Medicine (Berlin, Germany). 92: 151-64. PMID 24248265 DOI: 10.1007/S00109-013-1102-5 |
0.81 |
|
| 2013 |
Cai Z, Luo W, Zhan H, Semenza GL. Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proceedings of the National Academy of Sciences of the United States of America. 110: 17462-7. PMID 24101519 DOI: 10.1073/Pnas.1317158110 |
0.524 |
|
| 2013 |
Chen Z, Barbi J, Bu S, Yang HY, Li Z, Gao Y, Jinasena D, Fu J, Lin F, Chen C, Zhang J, Yu N, Li X, Shan Z, Nie J, ... ... Luo W, et al. The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3. Immunity. 39: 272-85. PMID 23973223 DOI: 10.1016/J.Immuni.2013.08.006 |
0.56 |
|
| 2013 |
Hubbi ME, Kshitiz, Gilkes DM, Rey S, Wong CC, Luo W, Kim DH, Dang CV, Levchenko A, Semenza GL. A nontranscriptional role for HIF-1α as a direct inhibitor of DNA replication Science Signaling. 6. PMID 23405012 DOI: 10.1126/Scisignal.2003417 |
0.734 |
|
| 2013 |
Chaturvedi P, Gilkes DM, Wong CC, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. The Journal of Clinical Investigation. 123: 189-205. PMID 23318994 DOI: 10.1172/Jci64993 |
0.787 |
|
| 2013 |
Chaturvedi P, Gilkes DM, Wong CCL, Kshitiz, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL. Erratum: Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis (Journal of Clinical Investigation (2013) 123: 1 (189-205) DOI: 10.1172/JCI64993) Journal of Clinical Investigation. 123. DOI: 10.1172/Jci69244 |
0.774 |
|
| 2013 |
Luo W, Chang R, Zhong J, Pandey A, Semenza GL. Abstract 2319: Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Cancer Research. 73: 2319-2319. DOI: 10.1158/1538-7445.Am2013-2319 |
0.687 |
|
| 2012 |
Luo W, Chang R, Zhong J, Pandey A, Semenza GL. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 109: E3367-76. PMID 23129632 DOI: 10.1073/Pnas.1217394109 |
0.689 |
|
| 2012 |
Luo W, Semenza GL. Emerging roles of PKM2 in cell metabolism and cancer progression. Trends in Endocrinology and Metabolism: Tem. 23: 560-6. PMID 22824010 DOI: 10.1016/J.Tem.2012.06.010 |
0.611 |
|
| 2011 |
Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, Luo W, Zeller K, Shimoda L, Topalian SL, Semenza GL, et al. Control of TH17/Treg balance by hypoxia-inducible factor 1 Cell. 146: 772-784. PMID 21871655 DOI: 10.1016/J.Cell.2011.07.033 |
0.495 |
|
| 2011 |
Luo W, Semenza GL. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget. 2: 551-6. PMID 21709315 DOI: 10.18632/Oncotarget.299 |
0.611 |
|
| 2011 |
Hubbi ME, Luo W, Baek JH, Semenza GL. MCM proteins are negative regulators of hypoxia-inducible factor 1. Molecular Cell. 42: 700-12. PMID 21658608 DOI: 10.1016/J.Molcel.2011.03.029 |
0.79 |
|
| 2011 |
Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, Cole RN, Pandey A, Semenza GL. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 145: 732-44. PMID 21620138 DOI: 10.1016/J.Cell.2011.03.054 |
0.654 |
|
| 2011 |
Rey S, Luo W, Shimoda LA, Semenza GL. Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue Blood. 117: 4988-4998. PMID 21389314 DOI: 10.1182/Blood-2010-11-321190 |
0.733 |
|
| 2011 |
Yuan G, Khan SA, Luo W, Nanduri J, Semenza GL, Prabhakar NR. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. Journal of Cellular Physiology. 226: 2925-33. PMID 21302291 DOI: 10.1002/Jcp.22640 |
0.596 |
|
| 2011 |
Luo W, Zhang H, Wong C, Gilkes D, Hu H, Semenza G. MS3-2: HIF-1, Metabolism, and Breast Cancer Metastasis. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Ms3-2 |
0.594 |
|
| 2010 |
Luo W, Zhong J, Chang R, Hu H, Pandey A, Semenza GL. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. The Journal of Biological Chemistry. 285: 3651-63. PMID 19940151 DOI: 10.1074/Jbc.M109.068577 |
0.526 |
|
| 2007 |
Wang Y, Luo W, Reiser G. Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family. The European Journal of Neuroscience. 26: 3159-68. PMID 18005059 DOI: 10.1111/J.1460-9568.2007.05938.X |
0.343 |
|
| 2007 |
Luo W, Wang Y, Reiser G. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Research Reviews. 56: 331-45. PMID 17915333 DOI: 10.1016/J.Brainresrev.2007.08.002 |
0.302 |
|
| 2007 |
Luo W, Wang Y, Reiser G. p24A, a type I transmembrane protein, controls ARF1-dependent resensitization of protease-activated receptor-2 by influence on receptor trafficking. The Journal of Biological Chemistry. 282: 30246-55. PMID 17693410 DOI: 10.1074/Jbc.M703205200 |
0.319 |
|
| 2007 |
Wang Y, Luo W, Reiser G. Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain. The Biochemical Journal. 401: 65-78. PMID 16942465 DOI: 10.1042/Bj20060732 |
0.362 |
|
| 2006 |
Wang Y, Luo W, Wartmann T, Halangk W, Sahin-Tóth M, Reiser G. Mesotrypsin, a brain trypsin, activates selectively proteinase-activated receptor-1, but not proteinase-activated receptor-2, in rat astrocytes. Journal of Neurochemistry. 99: 759-69. PMID 16903872 DOI: 10.1111/J.1471-4159.2006.04105.X |
0.301 |
|
| 2006 |
Wang Y, Luo W, Stricker R, Reiser G. Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. Journal of Neurochemistry. 98: 1046-60. PMID 16749907 DOI: 10.1111/J.1471-4159.2006.03950.X |
0.36 |
|
| 2006 |
Luo W, Wang Y, Hanck T, Stricker R, Reiser G. Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1. The Journal of Biological Chemistry. 281: 7927-36. PMID 16410250 DOI: 10.1074/Jbc.M510784200 |
0.376 |
|
| 2005 |
Luo W, Wang Y, Reiser G. Two types of protease-activated receptors (PAR-1 and PAR-2) mediate calcium signaling in rat retinal ganglion cells RGC-5. Brain Research. 1047: 159-67. PMID 15907810 DOI: 10.1016/J.Brainres.2005.04.040 |
0.329 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Wang Y, Luo W, Reiser G. The role of calcium in protease-activated receptor-induced secretion of chemokine GRO/CINC-1 in rat brain astrocytes. Journal of Neurochemistry. 103: 814-9. PMID 17666044 DOI: 10.1111/J.1471-4159.2007.04803.X |
0.294 |
|
| 2024 |
Hu L, Zhang Y, Guo L, Zhong H, Xie L, Zhou J, Liao C, Yao H, Fang J, Liu H, Zhang C, Zhang H, Zhu X, Luo M, von Kriegsheim A, ... ... Luo W, et al. Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma. Molecular Cell. PMID 38211588 DOI: 10.1016/j.molcel.2023.12.010 |
0.29 |
|
| 2020 |
Peng H, Wang Y, Luo W. Multifaceted role of branched-chain amino acid metabolism in cancer. Oncogene. PMID 32978521 DOI: 10.1038/s41388-020-01480-z |
0.288 |
|
| 2019 |
Wang Y, Luo W, Wang Y. PARP-1 and its associated nucleases in DNA damage response. Dna Repair. 102651. PMID 31302005 DOI: 10.1016/J.Dnarep.2019.102651 |
0.285 |
|
| 2022 |
Liu X, Wang J, Boyer JA, Gong W, Zhao S, Xie L, Wu Q, Zhang C, Jain K, Guo Y, Rodriguez J, Li M, Uryu H, Liao C, Hu L, ... ... Luo W, et al. Histone H3 proline 16 hydroxylation regulates mammalian gene expression. Nature Genetics. PMID 36347944 DOI: 10.1038/s41588-022-01212-x |
0.279 |
|
| 2021 |
Kumar R, Singh AK, Starokadomskyy P, Luo W, Theiss AL, Burstein E, Venuprasad K. Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis. Journal of Immunology (Baltimore, Md. : 1950). PMID 33504619 DOI: 10.4049/jimmunol.2000015 |
0.276 |
|
| 2022 |
Yang M, Wang C, Zhou M, Bao L, Wang Y, Kumar A, Xing C, Luo W, Wang Y. KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response. Nucleic Acids Research. PMID 35648484 DOI: 10.1093/nar/gkac471 |
0.274 |
|
| 2022 |
Zhang B, Peng H, Zhou M, Bao L, Wang C, Cai F, Zhang H, Wang JE, Niu Y, Chen Y, Wang Y, Hatanpaa K, Copland JA, DeBerardinis RJ, Wang Y, ... Luo W, et al. Targeting BCAT1 combined with α-ketoglutarate triggers metabolic synthetic lethality in glioblastoma. Cancer Research. PMID 35499760 DOI: 10.1158/0008-5472.CAN-21-3868 |
0.256 |
|
| 2008 |
Wang Y, Luo W, Reiser G. Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cellular and Molecular Life Sciences : Cmls. 65: 237-52. PMID 17965832 DOI: 10.1007/S00018-007-7288-3 |
0.255 |
|
| 2011 |
Luo W, Wang Y, Reiser G. Proteinase-activated receptors, nucleotide P2Y receptors, and μ-opioid receptor-1B are under the control of the type I transmembrane proteins p23 and p24A in post-Golgi trafficking. Journal of Neurochemistry. 117: 71-81. PMID 21219331 DOI: 10.1111/J.1471-4159.2011.07173.X |
0.255 |
|
| 2016 |
Luo W, Wang Y. HIF repressors under chronic hypoxia. Aging. PMID 26954058 |
0.215 |
|
| 2021 |
Ruan Z, Lu Q, Wang JE, Zhou M, Liu S, Zhang H, Durvasula A, Wang Y, Wang Y, Luo W, Wang Y. MIF promotes neurodegeneration and cell death via its nuclease activity following traumatic brain injury. Cellular and Molecular Life Sciences : Cmls. PMID 34921640 DOI: 10.1007/s00018-021-04037-9 |
0.171 |
|
| 2021 |
Lu H, Li R, Yang P, Luo W, Chen S, Bilal M, Xu H, Gu C, Liu S, Zhao Y, Geng C, Zhao L. iTRAQ-BASED Proteomic Analysis of the Mechanism of Fructose on Improving Fengycin Biosynthesis in . Molecules (Basel, Switzerland). 26. PMID 34684889 DOI: 10.3390/molecules26206309 |
0.169 |
|
| 2023 |
Carney SV, Banerjee K, Mujeeb A, Zhu B, Haase S, Varela ML, Kadiyala P, Tronrud CE, Zhu Z, Mukherji D, Gorla P, Sun Y, Tagett R, Núñez FJ, Luo M, ... Luo W, et al. Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36692427 DOI: 10.1158/1078-0432.CCR-22-1896 |
0.163 |
|
| 2021 |
Liu S, Zhou M, Ruan Z, Wang Y, Chang C, Sasaki M, Rajaram V, Lemoff A, Nambiar K, Wang JE, Hatanpaa KJ, Luo W, Dawson TM, Dawson VL, Wang Y. AIF3 splicing switch triggers neurodegeneration. Molecular Neurodegeneration. 16: 25. PMID 33853653 DOI: 10.1186/s13024-021-00442-7 |
0.159 |
|
| 2021 |
Liu S, Luo W, Wang Y. Emerging role of PARP-1 and PARthanatos in ischemic stroke. Journal of Neurochemistry. PMID 34241907 DOI: 10.1111/jnc.15464 |
0.139 |
|
| 2003 |
Luo WB, Dong L, Wang YP. Effect of magnesium lithospermate B on calcium and nitric oxide in endothelial cells upon hypoxia/reoxygenation. Acta Pharmacologica Sinica. 23: 930-6. PMID 12370098 |
0.133 |
|
| 2018 |
Wei L, Zhao S, Wang G, Zhang S, Luo W, Qin Z, Bi X, Tan Y, Meng M, Qin J, Qin H, Tian D, Zhang A. SMAD7 methylation as a novel marker in atherosclerosis. Biochemical and Biophysical Research Communications. PMID 29366786 DOI: 10.1016/j.bbrc.2018.01.121 |
0.129 |
|
| 2009 |
Luo W, Wang Y, Reiser G. The role of thrombin and thrombin receptors in the brain Thrombin: Physiology and Disease. 133-159. DOI: 10.1007/978-0-387-09637-7_8 |
0.062 |
|
| 2021 |
Han J, Meng X, Shen H, Luo W, Yao S, Yang J, Zhu Q, Tian Y, Wang S. Purification, molecular characterization of Lactocin 63 produced by Lactobacillus coryniformis FZU63 and its antimicrobial mode of action against Shewanella putrefaciens. Applied Microbiology and Biotechnology. PMID 34476515 DOI: 10.1007/s00253-021-11503-8 |
0.062 |
|
| 2005 |
Zhang W, Ren AG, Pei LJ, Hao L, Ou YL, Zhong XY, Zhang FR, Diao CH, Luo WB, Zhou LZ, Zhang ML, Li Z. [A case control study on the relationship between trace elements and human neural tube defects]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. 26: 772-6. PMID 16536302 |
0.055 |
|
| 2023 |
Zhuo Y, Chang J, Chen Y, Wen C, Chen F, Li W, Gao M, Luo W, Wan S, Song L, Zhu L. Value of contrast-enhanced MR angiography for the follow-up of treated brain arteriovenous malformations: systematic review and meta-analysis. European Radiology. PMID 37148354 DOI: 10.1007/s00330-023-09714-w |
0.037 |
|
| 2022 |
Li R, Luo W, Liu Y, Chen C, Chen S, Yang J, Wu P, Lv X, Liu Z, Ni L, Han J. The investigation on the characteristic metabolites of RLL68 during fermentation of beverage from by-products of black tea manufacture. Current Research in Food Science. 5: 1320-1329. PMID 36072509 DOI: 10.1016/j.crfs.2022.07.014 |
0.035 |
|
| 2023 |
Li R, Liu Y, Luo W, Huang H, Huang M, Chen C, Xiao R, Han J, Lü X. [Effect of FZU63 on the flavor quality of black tea beverage]. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology. 38: 4731-4743. PMID 36593206 DOI: 10.13345/j.cjb.220104 |
0.027 |
|
| Hide low-probability matches. |